Updated on 29 April 2013
Ms Anne Trimmer, CEO, Medical Technology Association of Australia (MTAA), Australia
The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community. Ms Anne Trimmer, CEO, Medical Technology Association of Australia (MTAA), speaks about the latest developments in Australia's medical technology industry and about MTAA future plans.
What is the total number of members of Medical Technology Association of Australia (MTAA)? What is the eligibility to become a member? What is the size of the medical technology industry in Australia?
The Medical Technology Association of Australia (MTAA) has currently 77 members and 10 associate members. The membership represents approximately 75 percent of the products listed on the private health insurance Prostheses List and approximately half of all medical products in the Australian market. Membership is open to all medical technology companies and subsidiaries in Australia. The size of the medical technology industry is estimated to be around $10 billion (AUS $10 billion).
Could you tell us about the major focus areas of MTAA?
MTAA focuses on public affairs and advocacy relevant to the industry. These focus on market access, commercial and regulatory issues, and on policies to advance growth of the industry. MTAA also administers the Medical Technology Industry Code of Practice, a self-regulatory industry code of ethics that regulates the interactions between industry and healthcare professionals, and (if applicable) consumers. MTAA delivers a range of professional development, communication and networking opportunities.
Could you kindly elaborate on the major developments, activities and achievements of MTAA in the last two years?
Over the past two years, MTAA has contributed significantly to policy development in the area of market access for technologies in the public and private health systems. Because of the duality of public and private systems in Australia, pathways to market are quite different. Both face challenges in the sustainability of healthcare delivery. MTAA's participation on an extensive range of policy committees ensures MTAA actively contributes to the development of policies in areas such as HTA, regulatory reforms, and private health insurance reimbursement. Other activities include the continuous development and review of ethical principles that underpin the industry self-regulatory Code of Practice.
Over the past two years MTAA has developed its Value of Technology (VOT) project to establish the cost-effectiveness of specific medical technologies. The research has supported submissions to government and has been used in advocacy activity. In 2012 MTAA developed a strategic industry policy agenda to increase government awareness of the industry's economic contribution and to argue for increased support for the development of the Australian medical technology sector. MTAA released a white paper Building a sustainable Australian medical technology industry as a roadmap for government and industry to work together more strategically to develop the policy levers industry needs to achieve growth in the sector.